153 Stock Overview
Researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Anhui Fengyuan Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.30 |
| 52 Week High | CN¥7.97 |
| 52 Week Low | CN¥4.26 |
| Beta | 0.75 |
| 11 Month Change | -14.61% |
| 3 Month Change | -4.50% |
| 1 Year Change | -20.98% |
| 33 Year Change | -24.44% |
| 5 Year Change | 15.94% |
| Change since IPO | -12.99% |
Recent News & Updates
Shareholder Returns
| 153 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.8% | -5.0% | -3.6% |
| 1Y | -21.0% | -13.7% | -16.0% |
Return vs Industry: 000153 underperformed the CN Pharmaceuticals industry which returned -13.7% over the past year.
Return vs Market: 000153 underperformed the CN Market which returned -16% over the past year.
Price Volatility
| 153 volatility | |
|---|---|
| 153 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 000153 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000153's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 4,670 | n/a | www.bbcayy.com |
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China. It offers products in various categories, which includes gynecology, respiratory system, hormonal, antipyretic analgesic, mental class, antiviral class, antibiotic class, oral anesthetic, masks class, urinary, water electrolyte balance, digestive system, cardiovascular class, Yinpian class, and nutrition and metabolism, as well as provides raw material drugs. The company also exports its products to Africa, Southeast Asia, Central Asia, Europe, and internationally.
Anhui Fengyuan Pharmaceutical Co., Ltd. Fundamentals Summary
| 153 fundamental statistics | |
|---|---|
| Market cap | CN¥2.42b |
| Earnings (TTM) | CN¥160.27m |
| Revenue (TTM) | CN¥4.19b |
15.4x
P/E Ratio0.6x
P/S RatioIs 153 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 153 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.19b |
| Cost of Revenue | CN¥3.15b |
| Gross Profit | CN¥1.04b |
| Other Expenses | CN¥878.81m |
| Earnings | CN¥160.27m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.34 |
| Gross Margin | 24.80% |
| Net Profit Margin | 3.83% |
| Debt/Equity Ratio | 42.0% |
How did 153 perform over the long term?
See historical performance and comparison